Recent data demonstrate that Nadecenemab , an experimental therapeutic , may lessen the development of mild Alzheimer's . This treatment focuses on removing amyloid plaques within the brain , a key https://opensocialfactory.com/story25656628/lecanemab-a-emerging-innovative-cognitive-approach